GABAPENTIN
Marketedupdated 2mo agoby ACI Healthcare USA Inc
Approvedcommunity read0 votes
indications
investigational
Epilepsy
all catalysts(59)
approval · 59
Sep 12, 2003
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 6, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 8, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 23, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 5, 2006
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
May 13, 2010
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 11, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 30, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 28, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 16, 2015
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that